CDA, Elsevier partner to publish Canadian Journal of Diabetes

Published on November 19, 2011 at 1:26 AM · No Comments

The Canadian Diabetes Association is pleased to announce that it has entered into an agreement with Elsevier to publish the Canadian Journal of Diabetes (CJD) beginning in January 2012.

CJD is Canada's only diabetes-oriented, peer-reviewed, interdisciplinary journal for diabetes healthcare professionals and scientists. It promotes the sharing and enhancement of knowledge to advance the prevention, cure and management of diabetes and related diseases. The journal publishes original research articles and expert reviews, ranging from basic sciences to clinical applications, education, public and population health, and health policy.

"We are very pleased to be partnering with Elsevier," said Michael Cloutier, President and CEO, Canadian Diabetes Association. "They are an innovative and leading publisher in medical information and, together, we will bring the Canadian Journal of Diabetes to new heights of excellence."

Andrew Miller, Executive Publisher, Global Medical Research, Elsevier stated, "We are very proud to be chosen as publisher for Canadian Journal of Diabetes. We look forward to further developing CJD in partnership with the Canadian Diabetes Association for the diabetes research and clinical-care communities."

Under the agreement with Elsevier, the Association will still own the journal, maintain copyright, and retain full editorial control. Elsevier will manage CJD publication, website features, print and online subscriptions, advertising, and marketing.

The decision to partner with Elsevier was reached by the Association after a long and thorough review process. The advantages of Elsevier's global reach and experience in the ever-changing field of scientific publication will not only benefit the CJD and its authors, but its readers as well.

Source:

Posted in: Medical Condition News | Healthcare News

Tags: , , , ,

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski
Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
New research suggests potential role for MEK inhibitors in type 2 diabetes